BIG
MGNX icon

Brooklyn Investment Group’s MacroGenics MGNX Stock Holding History

Brooklyn Investment Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,088
Closed -$3.54K – 2836
2024
Q4 		$3.54K Buy
+1,088
New +$3.92K ﹤0.01% 1314

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brooklyn Investment Group's MGNX Position: Q1 2025 in Review

Brooklyn Investment Group sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 1,088 shares — an estimated $3.54K sold.

Brooklyn Investment Group first reported a position in MGNX in Q4 2024 and held it in 1 quarter. The position peaked at $3.54K in Q4 2024. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

  • Brooklyn Investment Group reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 1,088 MacroGenics shares in Q1 2025, an estimated $3.54K.
  • Brooklyn Investment Group first reported a position in MacroGenics in Q4 2024 and held it in 1 quarter.
  • Brooklyn Investment Group's MacroGenics position peaked at $3.54K in Q4 2024.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on Brooklyn Investment Group's 13F filing for Q1 2025, filed 13 May 2025.